The Pharmacovigilance Program of Pakistan (PvPP) is launched with a broad objective to safe guard the health of people of Pakistan. Adverse drug Reactions (ADRs) are reported from all over the country to Pharmacovigilance Programme of Pakistan (PvPP), which also work in collaboration with the global ADR monitoring centres. Pharmacovigilance Programme of Pakistan (PvPP) monitors the ADRs among Pakistani population and will help the regulatory authorities in taking decision for safe use of medicines. I invite all the health care professionals and patients/consumers to join us in our mission to promote patient safety
Our main objective to collection, detection, assessment, monitoring, and prevention of adverse effectswith pharmaceutical products. PvPP will heavily focus on adverse drug reactions, or ADRs, which are defined as any response to a drug which is noxious and unintended, including lack of efficacy. (The condition that this definition only applies with the doses normally used for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological function was excluded with the latest amendment of the applicable legislation.) Medication errors such as overdose, and misuse and abuse of a drug as well as drug exposure during pregnancy and breastfeeding, are also of interest (even without adverse event itself), because they may result in an ADR
Scope and Objectives
To create a nation-wide system for patient safety reporting
To identify and analyse new signal from the reported cases
To analyse the benefit – risk ratio of marketed medications
To generate evidence based information on safety of medicines
To support evidence based information on safety of medicines
To support regulatory agencies in the decision-making process on use of medications
To communicate the safety information on use of medicines to various stakeholders to minimize the risk
To emerge as a national centre of excellence for pharmacovigilance activities
To collaborate with other national centres for the exchange of information and data management
To provide training and consultancy support to other national pharmacovigilance centres across globe
To promote rational use of medicine
To develop and implement Pharmacovigilance system in Pakistan.
To enroll, initially, all pmdc approved medical colleges in the program covering all over country.
To encourage healthcare professionals in reporting of adverse reaction to drugs, vaccines, medical devices and biological products.
Collection of case reports and data.
To expand Pharmacovigilance Programme to all hospitals (govt. & private) and centres of public health programs located across Pakistan.
To develop and implement electronic reporting system (e-reporting).
To develop reporting culture amongst healthcare professionals.
To make ADR reporting mandatory for healthcare professionals